StageZero Life Sciences Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.793307 million compared to USD 0.998203 million a year ago. Net loss was USD 0.401539 million compared to USD 1.28 million a year ago.
For the six months, sales was USD 1.56 million compared to USD 2.32 million a year ago. Net loss was USD 2.21 million compared to USD 1.87 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.